Literature DB >> 32219348

MYC needs MNT to drive B cells over the edge.

Siegfried Janz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32219348      PMCID： PMC7099328          DOI： 10.1182/blood.2019004766

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.

Authors:  Franz X Schaub; Varsha Dhankani; Ashton C Berger; Mihir Trivedi; Anne B Richardson; Reid Shaw; Wei Zhao; Xiaoyang Zhang; Andrea Ventura; Yuexin Liu; Donald E Ayer; Peter J Hurlin; Andrew D Cherniack; Robert N Eisenman; Brady Bernard; Carla Grandori
Journal:  Cell Syst       Date:  2018-03-28       Impact factor: 10.304

2.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

Authors:  D L Vaux; S Cory; J M Adams
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

3.  A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis.

Authors:  Jason M Link; Sara Ota; Zi-Qiang Zhou; Colin J Daniel; Rosalie C Sears; Peter J Hurlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

4.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

5.  Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.

Authors:  Hai Vu Nguyen; Cassandra J Vandenberg; Ashley P Ng; Mikara R Robati; Natasha S Anstee; Joel Rimes; Edwin D Hawkins; Suzanne Cory
Journal:  Blood       Date:  2020-03-26       Impact factor: 22.113

Review 6.  The BCL-2 arbiters of apoptosis and their growing role as cancer targets.

Authors:  Jerry M Adams; Suzanne Cory
Journal:  Cell Death Differ       Date:  2017-11-03       Impact factor: 15.828

7.  Mnt modulates Myc-driven lymphomagenesis.

Authors:  Kirsteen J Campbell; Cassandra J Vandenberg; Natasha S Anstee; Peter J Hurlin; Suzanne Cory
Journal:  Cell Death Differ       Date:  2017-08-11       Impact factor: 15.828

8.  MNT and Emerging Concepts of MNT-MYC Antagonism.

Authors:  Guang Yang; Peter J Hurlin
Journal:  Genes (Basel)       Date:  2017-02-20       Impact factor: 4.096

Review 9.  The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.

Authors:  Patrick A Carroll; Brian W Freie; Haritha Mathsyaraja; Robert N Eisenman
Journal:  Front Med       Date:  2018-07-27       Impact factor: 4.592

Review 10.  Bivalent Ligands for Protein Degradation in Drug Discovery.

Authors:  Marcel Scheepstra; Koen F W Hekking; Luc van Hijfte; Rutger H A Folmer
Journal:  Comput Struct Biotechnol J       Date:  2019-01-25       Impact factor: 7.271
  10 in total
  1 in total

1.  miR-22 Suppresses EMT by Mediating Metabolic Reprogramming in Colorectal Cancer through Targeting MYC-Associated Factor X.

Authors:  Shusen Xia; Xianyan Wang; Yi Wu; Tong Zhou; Hongpeng Tian; Zuoliang Liu; Lifa Li; Zaihua Yan; Guangjun Zhang
Journal:  Dis Markers       Date:  2022-08-25       Impact factor: 3.464
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.